Navigation Links
A safer vaccination for Alzheimer's disease?
Date:10/11/2011

The research shows that in addition to the major histocompatibility complex (MHC) molecules, which present the antigen vaccine to the immune cells, genetic factors, that control some immune cells, influence the quality of response to vaccinations. The results could make it possible to prevent neuroinflammatory reactions, which are major obstacles preventing the use of the vaccination in humans. This study has just been published in the Journal of Immunology. Since the beginning of the 2000s, research into Alzheimer's disease has partly focussed on studying a vaccination composed of amyloid-β peptide (A), the accumulation of which in the brain is thought to trigger the disease. Vaccinations with this peptide caused serious neuroinflammatory reactions in 6% of patients. To develop a safer and more effective treatment, it is therefore essential to understand the factors that influence the body's responses to peptide A.

The joint Inserm/UPMC research team, led by Pierre Aucouturier, with Ccile Toly-Ndour and Guillaume Dorothe, conducted its research on mice with different forms of major histocompatibility complex (MHC). The role of these molecules is to present the antigens to the immune cells and they have a wide genetic diversity, which could explain the different responses. Indeed, after vaccination with the peptide A, mice with different MHC had different immune cell reactions. Researchers then pushed their studies further. By expressing the MHC from one line of mice to another, they demonstrated that factors in independent from MHC, but related to the genetic background, have a massive influence on the anti-A response. They then proved that these factors involve a sub-population of white blood cells (regulatory T cells).

These results provide a new direction to orientate immune cells advantageously, thus improving the immunotherapeutic approach, which remains one of the major hopes in the fight against Alzheimer's. However, these observations made on mice still require validation on human patients.


'/>"/>
Contact: Claire de Thoisy-Mchin
claire.de_thoisymechin@upmc.fr
33-014-427-2334
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Related medicine news :

1. Nanotechnology holds promise for safer breast implants
2. CDC Moves to Make Organ Transplantation Safer
3. For safer food imports, Teach foreign lab workers US requirements
4. Mothers postpartum oxycodone use: No safer for breastfed infants than codeine
5. Newer techniques are making cardiac CT safer for children
6. Safer sex: Study examines sexual communication in transgender community
7. High-Risk Surgeries Getting Safer: Study
8. Fraunhofer MEVIS: New procedure to make brain surgery safer
9. Short antibiotic courses safer for breathing-tube infections in children
10. Unreliable outcomes measures hamper efforts to assure better, safer care
11. Safer CT scanning for children developed at the Queen Silvia Childrens Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... chronic conditions reported skipping doses or not filling a prescription because they could ... rates of cost-related problems getting medications were 30-60%*. At the same ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Sideline Products ... the company met national TV host Tom Seay and his production crew. Tom ... favorite among equestrians around the world. Saddle Sidekicks will be featured on April ...
(Date:2/22/2017)... ... February 22, 2017 , ... The first-ever National ... organizations, advocates, and individuals join together to increase recognition about the risks of ... lives. , “Today we mark a nationwide movement to raise awareness about a ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine ... practices, is featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to ... number of neurosurgeons in Michigan performing minimally invasive back surgery that often results ...
(Date:2/22/2017)... ... February 22, 2017 , ... Michael J. Hennessy Associates, ... connecting healthcare technology professionals and other key stakeholders with an array of valuable ... on March 1, announced Michael J. Hennessy, Jr., president of MJH Associates. ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... PUNE, India , February 22, 2017 ... "Automated Radio Synthesis Modules Market: Global Opportunity Analysis and Industry ... was worth $20 million in 2015 and projected to reach ... from 2016 to 2022. North America ... revenues and unit volumes, whereas Asia-Pacific ...
(Date:2/22/2017)... MERIDEN, Conn. , Feb. 22, 2017   ... and maker of Flublok® Influenza Vaccine , announced ... The Partnership for Influenza Vaccine Introduction (PIVI) and the ... the devastating impacts of the flu.  The doses of ... of Mongolia for health care ...
(Date:2/22/2017)... and PUNE, India , February ... report published by Allied Market Research, titled, "Radiology Information System ... Opportunity Analysis and Industry Forecast, 2014-2022," the radiology information system ... projected to reach $941 million by 2022, growing at a ... information systems segment held over three-fifths share of the total ...
Breaking Medicine Technology: